Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial.
Vincent ThijsGeoffrey C CloudNigel GilchristBrooke ParsonsForum TilvawalaJan HoLara RuthnamVimal StanislausNikola SpriggMarion WalkerPhilip M BathLeonid ChurilovJulie BernhardtPublished in: European stroke journal (2024)
PESTO aims to provide level 1 evidence on the safety and efficacy of perispinal etanercept in patients with long-term disabling effects of stroke.
Keyphrases
- double blind
- atrial fibrillation
- rheumatoid arthritis
- placebo controlled
- ankylosing spondylitis
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- clinical trial
- randomized controlled trial
- phase iii
- open label
- study protocol
- phase ii
- disease activity
- adipose tissue
- cross sectional
- systemic lupus erythematosus